FDA inspection flags data integrity and manufacturing lapses at Dabur plant, raising compliance risks, export concerns, and quality scrutiny in the US market.
The article explores GLP-1 pathways, berberine, and Metaberine in metabolic health, highlighting multi-pathway, science-backed solutions for better glycemic control and long-term metabolic balance.
.jpeg)
Bengaluru Ebola scare ends negative, but triggers health alert as authorities ramp up airport screening, surveillance, and isolation protocols amid global outbreak concerns.
India’s heatwave crisis is turning into a public health emergency, with rising heatstroke deaths, underreported mortality, and growing strain on healthcare systems.
.jpeg)
Patent exclusivity expiry of $200–300B drugs is reshaping India’s pharma logistics. Rising generics, biosimilars, and cold-chain demand are driving investments in air cargo, ports, and compliant supply chains.
Hidden thyroid risk in young India crosses 50%, study finds. Experts flag subclinical thyroid disorders, delayed diagnosis, and rising need for preventive screening.
India has stepped up its global health response after the World Health Organization (WHO) declared an Ebola emergency, with India sending Ebola aid to Africa following the WHO health alert to support countries struggling with a growing outbrea...
Indian pharma is being hit by Gulf tensions and South Asia trade curbs, as rising geopolitical uncertainty and regional market restrictions begin to affect the smooth flow of medicines and raw materials. The sector, known globally for supplyin...
The term Polyendocrine Metabolic Ovarian Syndrome (PMOS) is quickly gaining attention in the medical world as doctors and health experts push to replace the widely used term Polycystic Ovary Syndrome (PCOS).
India's drug regulator has banned cosmetic injections amid a surge in adverse reactions, including deaths and rare immune responses, linked to unregulated beauty injections administered outside proper medical settings.
, CDSCO.jpg)